Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Spero Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026

$SPROPress releaseAug 4, 2026, 4:01 PM ETRead the release

Spero Therapeutics announced it will report second quarter 2026 financial results on Wednesday, August 12, 2026, after market close. Management will host a conference call and live webcast at 5:00 pm ET to discuss the results and provide a business and pipeline update.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.